Method for coating fine particles with lipid membrane

Abstract

A method for coating fine particles with lipid membrane, characterized in that, the rate of a polar organic solvent in an aqueous solution containing the polar organic solvent where the fine particles are dispersed and lipid is dissolved, is decreased.

1 - 19 . (canceled) 
     
     
         20 . A method for coating a complex of a nucleic acid and a liposome with closed vesicles of a lipid bilayer, the liposome comprising cationic lipid, the complex obtained by mixing the nucleic acid and the liposome in water, which consists of the steps of (i) and (ii):
 (i) suspending the complex in an aqueous solution comprising:   water,   polar organic solvent(s) selected from an alcohol, a glycol and a polyalkylene glycol, and   lipid(s) selected from phospholipid, glyceroglycolipid, sphingoglycolipid, cholesterol and synthetic lipid,   wherein the complex has a diameter of 10 nm to 1,000 nm;   wherein the lipid(s) is dissolved in the aqueous solution; and   wherein the aqueous solution does not comprise chloroform, and   (ii) adding water to the aqueous solution in which the complex is suspended, so as to decrease the vol % concentration of the polar organic solvent(s) in the aqueous solution, whereby the complex is coated with closed vesicles of the lipid bilayer formed of the lipid(s).   
     
     
         21 . A method for coating a complex of a nucleic acid and a liposome with closed vesicles of a lipid bilayer, the liposome comprising cationic lipid the complex obtained by mixing the nucleic acid and the liposome in water, which consists of the steps of (i), (ii), (iii) and (iv):
 (i) suspending the complex in liquid A comprising:   water, and   polar organic solvent(s) selected from an alcohol, a glycol and a polyalkylene glycol,   wherein the complex has a diameter of 10 nm to 1,000 nm, and   wherein the aqueous solution does not comprise chloroform,   (ii) dissolving lipid(s) selected from phospholipid, glyceroglycolipid, sphingoglycolipid, cholesterol and synthetic lipid, in liquid B consisting essentially of: polar organic solvent(s) selected from an alcohol, a glycol and a polyalkylene glycol, and optionally water,   (iii) mixing the liquid A and the liquid B, to obtain liquid C in which the complex is suspended, and   (iv) adding water to the liquid C so as to decrease the vol % concentration of the polar organic solvent(s), to obtain liquid D, and whereby the complex is coated with closed vesicles of the lipid bilayer formed of the lipid(s).   
     
     
         22 . The method according to  claim 21 , wherein the concentrations of the polar organic solvent(s) in the liquid A and the liquid B are 60 to 90 vol %. 
     
     
         23 . The method according to  claim 22 , wherein the concentration of the polar organic solvent(s) in the liquid D is 50 vol % or less. 
     
     
         24 . The method according to  claim 20 , wherein the complex contains a water-soluble polymer derivative. 
     
     
         25 . The method according to  claim 21 , wherein the complex contains a water-soluble polymer derivative. 
     
     
         26 . The method according to  claim 20 , wherein the liposome comprises a phospholipid and a dextran sulfate sodium salt. 
     
     
         27 . The method according to  claim 21 , wherein the liposome comprises a phospholipid and a dextran sulfate sodium salt. 
     
     
         28 . The method according to  claim 20 , wherein the alcohol is ethanol. 
     
     
         29 . The method according to  claim 21 , wherein the alcohol is ethanol. 
     
     
         30 . The method according to  claim 20 , wherein the glycol is a propylene glycol. 
     
     
         31 . The method according to  claim 21 , wherein the glycol is a propylene glycol. 
     
     
         32 . The method according to  claim 20 , wherein the polyalkylene glycol is polyethylene glycol. 
     
     
         33 . The method according to  claim 21 , wherein the polyalkylene glycol is polyethylene glycol. 
     
     
         34 . The method according to  claim 24 , wherein the water-soluble polymer derivative is one or more member(s) selected from polyethylene glycolated lipid, a polyethylene glycol alkyl ether, a polyethylene glycol castor oil derivative, a polyethylene glycol sorbitan fatty acid ester, a polyethylene glycol stearate, a copolymer of ethylene glycol with propylene glycol and a glycerol ester. 
     
     
         35 . The method according to  claim 20 , wherein the lipid(s) is one or more member(s) selected from phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, phosphatidic acid, phosphatidylglycerol, phosphatidylinositol, lysophosphatidylcholine, sphingomyelin, polyethylene glycolated phospholipid, egg yolk lecithin, soybean lecithin and hydrogenated phospholipid. 
     
     
         36 . The method according to  claim 21 , wherein the lipid(s) is one or more member(s) selected from phosphatidylcholine, phosphatidylethoanolamine, phosphatidylserine, phosphatidic acid, phosphatidylglcerol, phosphatidylinositol, lysophosphatidylcholine, sphingomyelin, polyethylene glycolated phospholipid, egg yolk lecithin, soybean lecithin and hydrogenated phospholipid. 
     
     
         37 . The method according to  claim 20 , wherein the lipid(s) is a mixture of egg yolk phosphatidylcholine (EggPC) and 1,2-distearoyl-sn-glycero-3-phosphatidylethanolamine-N-(polyethyleneglycol 2000) (PEG-DSPE). 
     
     
         38 . The method according to  claim 21 , wherein the lipid(s) is a mixture of egg yolk phosphatidylcholine (EggPC) and 1,2-distearoyl-sn-glycero-3-phosphatidylethanolamine-N-(polyethyleneglycol 2000) (PEG-DSPE). 
     
     
         39 . The method according to  claim 20 , wherein the polar organic solvent(s) is ethanol. 
     
     
         40 . The method according to  claim 21 , wherein the polar organic solvent(s) is ethanol.